Braveheart Bio
Latest round
- Series A
Last raised
- Nov 2025
Total raised
- $185M
Investors
- 5
About Braveheart Bio
Braveheart Bio, Inc. is focused on creating therapies for hypertrophic cardiomyopathy (HCM). The company is headquartered in San Francisco, US. The founder's history is not specified.Braveheart Bio is engaged in advancing treatments for hypertrophic cardiomyopathy (HCM) through investigational therapies that target overactive myosin. These therapies aim to improve heart performance by counteracting excessive force during contractions, which causes abnormal thickening of the heart muscle, primarily in the left ventricle.Braveheart's revenue model centers on partnerships and collaborations within the biopharmaceutical sector, focusing on delivering novel therapies to healthcare providers and institutions. Revenue is generated through licensing agreements and collaborations with pharmaceutical companies, facilitating distribution and access to investigational treatments. The business structure prioritizes relationships with healthcare systems and engagement with clinical trial networks, ensuring effective distribution upon regulatory approval. The company aims to expand its market presence into Europe and Asia by 2026, addressing the global need for effective HCM treatments. The investments will be directed toward further clinical development and regulatory approval processes to enhance access to their innovative therapies.
Who invested in Braveheart Bio
5 investors across 1 round
See all investors in Braveheart Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 5, 2025
Amount
$185M
Investors
Questions about Braveheart Bio
Who invested in Braveheart Bio?
Braveheart Bio has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Braveheart Bio raised?
Braveheart Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Braveheart Bio last raise money?
Braveheart Bio's most recent round on record is a Series A, in Nov 2025.
What does Braveheart Bio do?
Braveheart Bio is a healthcare specialists company.
Where is Braveheart Bio headquartered?
Braveheart Bio is headquartered in San Francisco, US.
Which VCs invest in companies like Braveheart Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at Braveheart Bio's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series A
Raising like Braveheart Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.